Filing Details

Accession Number:
0001209191-20-017732
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-10 17:00:20
Reporting Period:
2020-03-04
Accepted Time:
2020-03-10 17:00:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1651311 Merus N.v. MRUS Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1790357 Mark Throsby C/O Merus N.v.
Yalelaan 62
Utrecht P7 3584 CM
Evp & Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2020-03-04 368 $18.10 44,155 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
  2. Amount represents the weighted average price of shares sold, which ranged from $17.73 to $18.19. Details of individual transactions are available upon request.